Industry News

Soaring generic drug prices draw Senate scrutiny
U.S. FDA Grants Fast Track Designation to Novavax' RSV F-Protein Nanoparticle Vaccine for Protection of Infants Via Maternal Immunization
GlaxoSmithKline Reports EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade
Shire To Cut Costs With US Site Consolidation, Appoints Interim CFO
Aurora Spine Receives FDA 510(k) Clearance for Pre-Packaged Sterile ZIP 51(TM) MIS Interspinous Fixation Implant
Actavis to Buy Botox-Maker Allergan for $66 Billion
Shire To Cut Costs With US Site Consolidation, Appoints Interim CFO
Bristol-Myers Squibb to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland
Merck KGaA, Darmstadt, Germany, Announces Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
Merck KGaA, Darmstadt, Germany, Announces Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology
GlaxoSmithKline Reports EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade
Medidata Collaborates with GlaxoSmithKline on Mobile Health Initiative to Test Novel Technology for Clinical Trial Optimization
GlaxoSmithKline Reports EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade
Janssen Pharmaceuticals - U.S. FDA Approves Supplemental New Drug Applications for Once-Monthly Long-Acting Therapy INVEGA SUSTENNA (paliperidone palmitate) for the Treatment of Schizoaffective Disorder
Acology in Discussions With Altura Pharmaceutical for 8 State Distribution Agreement for the Medtainer
Changes in Senate raise hopes for repeal of medical device tax
FDA approves Lemtrada for multiple sclerosis
Graphic labels are seen as key to anti-smoking campaign
Sun Pharma Asked to Revise Ranbaxy $3.2 Billion Merger Plan
United States : Dealmaking on track for blockbuster 2014 as technology M&A soars
Nigerian pharma industry gets WHO boost
Cadila looks to set up $16M fund to back pharma startups
FDA Approves Genentech�s Avastin (bevacizumab) Plus Chemotherapy to Treat Women with Platinum-Resistant Recurrent Ovarian Cancer
United States : US FDA approval gained by Par Pharmas vasopressin injection
Pallone, Gillibrand Urge FDA to Evaluate Safety of Plastic Microbeads in Oral Care Products